Spruce Biosciences insider ownership report

SPRUCE BIOSCIENCES, INC. filed a Form 3 identifying Corwin Dale Hooks, its Chief Commercial Officer, as a reporting person.

Accepted by SEC EDGAR 03/09/2026 - 04:07 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

SPRUCE BIOSCIENCES, INC. filed a Form 3 identifying Corwin Dale Hooks, its Chief Commercial Officer, as a reporting person. The filing lists no transactions, indicating that no purchases, sales, acquisitions, or dispositions of SPRB securities are reported in this initial ownership statement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SPRB Form 3 filing for Corwin Dale Hooks show?

The Form 3 for SPRUCE BIOSCIENCES, INC. (SPRB) identifies Corwin Dale Hooks as a reporting person and Chief Commercial Officer. The transactions section is empty, so no purchases, sales, acquisitions, or dispositions of company securities are reported in this filing.

Does the SPRB Form 3 report any stock transactions by Corwin Dale Hooks?

No, the Form 3 for Corwin Dale Hooks reports zero transactions. All transaction counts and share amounts for buys, sells, acquisitions, and dispositions are listed as 0, indicating no insider trading activity is disclosed in this filing.

What role does Corwin Dale Hooks hold at Spruce Biosciences (SPRB)?

Corwin Dale Hooks is identified as Chief Commercial Officer of SPRUCE BIOSCIENCES, INC. in the Form 3 filing. He is reported as an officer, not a director and not a ten percent owner, based on the structured insider data provided.

How many SPRB shares did Corwin Dale Hooks buy or sell in this Form 3?

According to the insider data, buyShares and sellShares are both 0 for this Form 3. The net buy/sell shares figure is also 0, and the net direction is neutral, meaning no share purchases or sales are reported.

What is the overall transaction direction in the SPRB Form 3 for Corwin Dale Hooks?

The overall transaction direction is recorded as neutral. Buy, sell, acquire, dispose, and other transaction counts are all 0, so the filing functions as an identification of the reporting person without showing any trading activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hooks Corwin Dale

(Last) (First) (Middle)

C/O SPRUCE BIOSCIENCES, INC.

611 GATEWAY BOULEVARD, SUITE 740

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/09/2026

3. Issuer Name and Ticker or Trading Symbol
SPRUCE BIOSCIENCES, INC. [ SPRB ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Samir Gharib, Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.